We confirmed recurrent mutations in PCa-specific genes, but also identified many new genes not known to be mutated, like TET1. We discovered a strong decrease in DNA hydroxymethylation in HRPC compared to surrounding non-tumor tissue. Here, TET1 is linked to neoplasm.